Clinical Trial Update: Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis [Phase 3]

View source ↗

Summary

A Phase 3 trial assessed the safety and efficacy of adding adalimumab to methotrexate versus methotrexate alone and placebo in adults with moderate to severe ch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Abbott | Conditions: Psoriasis | Phase 3 | Status: COMPLETED